RELATIONSHIPS INVOLVING THE CONCERN OF DRUG OVERDOSE AND BENZODIAZEPINE DOSAGE FOR SLEEP PROBLEMS: A CLINICAL DIAGNOSTIC BASED CROSS-SECTIONAL STUDY

Main Article Content

Shahzada Bilal Syed
Muhammad Umair Riaz
Gul Mehnaz
Ayesha Iftikhar
Tariq Mahmood Khan
Sameen Zainab
Saima Bukhari
Rabia Zulfiqar

Keywords

concern, drug overdose, benzodiazepine, dosage, sleep problems

Abstract

Adolescent sleep disturbances are treated with benzodiazepines; nonetheless, overdoses on these drugs do happen frequently in conjunction with opioids. Our research sought to determine the associations between the risk of medication overdose and the dosage of benzodiazepines used to treat sleep disorders. The study analyzed patient-level information from April 2021 to May 2023 in various settings in Pakistan, focusing on young individuals diagnosed with sleep disturbances and starting therapy with benzodiazepines or alternative medications. The study used the Kaplan-Meier estimator to estimate the cumulative incidence of overdoses, Cox proportional hazards regression models to estimate hazard ratios and 95% confidence intervals, and logistic regression to estimate propensity scores. The study aimed to identify young individuals with sleep disturbances and their adherence to benzodiazepines or alternative medications. The study found that benzodiazepines, particularly those prescribed for sleep disorders, can increase the risk of drug overdose in young individuals. The adjusted 6-month risk of drug overdose was 1.6% for benzodiazepine initiators, compared to 0.6% for comparator therapy. Young adults were more likely to experience drug overdose, with a higher risk of benzodiazepine treatment.

Abstract 141 | Pdf Downloads 47

References

1. Liebrenz, M, Gehring, M-T, Buadze, A, and Caflisch, C. High-dose benzodiazepine dependence: a qualitative study of patients’ perception on cessation and withdrawal. BMC Psychiatry. (2015) 15:116. doi: 10.1186/s12888-015-0493-y
2. Morbioli, L, and Lugoboni, F. High-dose benzodiazepine dependence among healthcare professionals: A neglected phenomenon. Med Sci Law. (2021) 61:42–5.
doi: 10.1177/0025802420928650
3. Ohayon, MM, and Lader, MH. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry. (2002) 63:817–25. doi: 10.4088/JCP.v63n0912
4. Braquehais, MD, Lusilla, P, Bel, MJ, Navarro, MC, Nasillo, V, Díaz, A, et al. Dual diagnosis among physicians: a clinical perspective. J Dual Diagn. (2014) 10:148–55.
doi: 10.1080/15504263.2014.929331
5. Riemann D, Baglioni C, Bassetti C, et al.. European guidelines for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675-700. doi: 10.1111/jsr.12594
6. Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307-349. doi: 10.5664/jcsm.6470
7. Owens JA, Moturi S. Pharmacologic treatment of pediatric insomnia. Child Adolesc Psychiatr Clin N Am. 2009;18(4):1001-1016. doi: 10.1016/j.chc.2009.04.009
8. Bushnell GA, Crystal S, Olfson M. Prescription benzodiazepine use in privately insured U.S. children and adolescents. Am J Prev Med. 2019;57(6):775-785. doi: 10.1016/j.amepre.2019.07.006
9. Huerta C, Abbing-Karahagopian V, Requena G, et al.. Exposure to benzodiazepines (anxiolytics, hypnotics, and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project. Pharmacoepidemiol Drug Saf. 2016;25(suppl 1):56-65. doi: 10.1002/pds.3825
10. Agarwal SD, Landon BE. Patterns in outpatient benzodiazepine prescribing in the United States. JAMA Netw Open. 2019;2(1):e187399. doi: 10.1001/jamanetworkopen.2018.7399
11. Sidorchuk A, Isomura K, Molero Y, et al.. Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: a total population register-linkage study. PLoS Med. 2018;15(8):e1002635. doi: 10.1371/journal.pmed.1002635
12. Owens JA, Rosen CL, Mindell JA, Kirchner HL. Use of pharmacotherapy for insomnia in child psychiatry practice: a national survey. Sleep Med. 2010;11(7):692-700.
doi: 10.1016/j.sleep.2009.11.015
13. Paulozzi LJ, Strickler GK, Kreiner PW, Koris CM; Centers for Disease Control and Prevention (CDC). Controlled substance prescribing patterns—prescription behavior surveillance system, eight states, 2013. MMWR Surveill Summ. 2015;64(9):1-14. doi: 10.15585/mmwr.ss6409a1
14. Bachhuber MA, Hennessy S, Cunningham CO, Starrels JL. Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996-2013. Am J Public Health. 2016;106(4):686-688. doi: 10.2105/AJPH.2016.303061
15. Toce MS, Michelson KA, Hudgins JD, Olson KL, Bourgeois FT. Trends in benzodiazepine prescribing for U.S. adolescents and young adults from 2008 to 2019. JAMA Pediatr. 2022;176(3):312-313. doi: 10.1001/jamapediatrics.2021.5122
16. Chhangani B, Greydanus DE, Patel DR, Feucht C. Pharmacology of sleep disorders in children and adolescents. Pediatr Clin North Am. 2011;58(1):273-291, xiii. Doi: 10.1016/j.pcl.2010.11.003
17. Jones JD, Mogali S, Comer SD. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend. 2012;125(1-2):8-18.
doi: 10.1016/j.drugalcdep.2012.07.004
18. Brunton LL, Chabner BA, Knollman BC, eds. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 12th ed. The McGraw-Hill Companies Inc; 2011.
19. U.S. Food & Drug Administration. FDA is requiring boxed warning updated to improve the safe use of benzodiazepine drug class. Accessed October 5, 2020. https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class
20. Jann M, Kennedy WK, Lopez G. Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics. J Pharm Pract. 2014;27(1):5-16. doi: 10.1177/0897190013515001
21. Linnoila MI. Benzodiazepines and alcohol. J Psychiatr Res. 1990;24(suppl 2):121-127. doi: 10.1016/0022-3956(90)90043-P
22. Sun EC, Dixit A, Humphreys K, Darnall BD, Baker LC, Mackey S. Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ. 2017;356:j760. doi: 10.1136/bmj.j760
23. National Institute on Drug Abuse. Overdose death rates. Accessed September 10, 2020. https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates
24. Austin AE, Proescholdbell SK, Creppage KE, Asbun A. Characteristics of self-inflicted drug overdose deaths in North Carolina. Drug Alcohol Depend. 2017;181:44-49. doi: 10.1016/j.drugalcdep.2017.09.014
25. Bushnell G, Samples H, Gerhard T, Calello DP, Olfson M. Benzodiazepine and stimulant prescriptions before overdose in youth. Pediatrics. 2022;149(4):e2021055226.
doi: 10.1542/peds.2021-055226
26. Xu KY, Hartz SM, Borodovsky JT, Bierut LJ, Grucza RA. Association between benzodiazepine use with or without opioid use and all-cause mortality in the United States, 1999-2015. JAMA Netw Open. 2020;3(12):e2028557. doi: 10.1001/jamanetworkopen.2020.28557
27. Merikangas KR, He JP, Burstein M, et al.. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication–Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2010;49(10):980-989. doi: 10.1016/j.jaac.2010.05.017
28. Conway KP, Swendsen J, Husky MM, He JP, Merikangas KR. Association of lifetime mental disorders and subsequent alcohol and illicit drug use: results from the National Comorbidity Survey–Adolescent Supplement. J Am Acad Child Adolesc Psychiatry. 2016;55(4):280-288. doi: 10.1016/j.jaac.2016.01.006
29. Anand Gopal & Nandita Shetty (2023). Literature Review on Comparison of Efficacy and Safety of Mometasone Furoate 0.1% Gel Versus Mometasone Furoate 0.1% Cream and Adapalene Gel 0.1%. Dinkum Journal of Medical Innovations, 2(02):57-71.
30. Pooja Agarwal & Komal Mishra (2023). Examining the Long-Term Effects of Breastfeeding on Infants’ Neurocognitive and Gross Development. Dinkum Journal of Medical Innovations, 2(02):72-78.
31. Mutahara Ahsan & Mashal Ali (2023). Systematic Literature Review on Individuals’ Satisfaction of Existence Affected by Bipolar Disorder. Dinkum Journal of Medical Innovations, 2(02):50-56.
32. Muhammad Ayan & Ayesha Pervaiz Cheema (2023). Patients’ Perceptions of Post-Mastectomy Mammary Reconstruction: Contributing Variables. Dinkum Journal of Medical Innovations, 2(02):42-49.
33. Ray WA, Stein CM, Murray KT, et al.. Association of antipsychotic treatment with risk of unexpected death among children and youths. JAMA Psychiatry. 2019;76(2):162-171. doi: 10.1001/jamapsychiatry.2018.3421
34. Owens JA. Pharmacotherapy for insomnia in children and adolescents: a rational approach. UpToDate. 2022. Accessed March 4, 2021. https://www.uptodate.com/contents/pharmacotherapy-for-insomnia-in-children-and-adolescents-a-rational-approach/print
35. Lavigne JE, Hur K, Kane C, Au A, Bishop TM, Pigeon W.R. Prescription medications for the treatment of insomnia and risk of suicide attempt: a comparative safety study. J Gen Intern Med. 2019;34(8):1554-1563. doi: 10.1007/s11606-019-05030-6

Most read articles by the same author(s)